Role of klotho on antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression and suicidal ideation
Journal of Affective Disorders · 2023-11 · 340 · 471-475
DOI: 10.1016/j.jad.2023.08.061 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2023-11. Verfasst von Mu-Hong Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tun…. Hauptthemen laut MEDLINE: Ketamine, Major Depressive Disorder, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
OBJECTIVE: Previous studies have found an association between klotho, an anti-aging hormone, and major depressive disorder. However, whether low-dose ketamine infusion alters klotho levels among patients with treatment-resistant depression (TRD) remains unknown. METHODS: In total, 48 patients with TRD and strong suicidal ideation were randomly assigned to a single 0.5 mg/kg ketamine or 0.045 mg/kg midazolam regimen and were subjected to a 2-week follow-up. Depressive and suicidal symptoms were assessed before the infusion and during the follow-up. The serum levels of klotho were assessed at baseline and 3 days postinfusion. RESULTS: A generalized linear model with adjustment of baseline klotho levels showed that, despite the fact that ketamine did not significantly increase levels of klotho, patients in the ketamine group had higher levels of klotho at Day 3 postinfusion than patients in the midazolam group (p = 0.043). However, we found no association between changes in klotho levels and changes in depressive and suicidal symptoms (all p > 0.05). Higher klotho levels at baseline were associated with poorer antidepressant effect of low-dose ketamine during postinfusion follow-up. DISCUSSION: Klotho may play a role in the antidepressant effect of low-dose ketamine. Additional molecular studies are necessary to elucidate the neuromechanisms of TRD, ketamine, and klotho.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Institute of Brain Science, National Yan…
- Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Medical Research, Taipei V…
Zitieren
APA
Chen, M. H., Bai, Y. M., Wu, H. J., Li, C. T., Lin, W. C., Tsai, S. J., Su, T. P., & Tu, P. C. (2023). Role of klotho on antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression and suicidal ideation. Journal of Affective Disorders, 340, 471-475. https://doi.org/10.1016/j.jad.2023.08.061
Vancouver
Chen MH, Bai YM, Wu HJ, Li CT, Lin WC, Tsai SJ, et al. Role of klotho on antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression and suicidal ideation. Journal of Affective Disorders. 2023;340:471-475. doi:10.1016/j.jad.2023.08.061
BibTeX
@article{Chen2023,
author = {Chen, Mu-Hong and Bai, Ya-Mei and Wu, Hui-Ju and Li, Cheng-Ta and Lin, Wei-Chen and Tsai, Shih-Jen and Su, Tung-Ping and Tu, Pei-Chi},
title = {Role of klotho on antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression and suicidal ideation},
journal = {Journal of Affective Disorders},
year = {2023},
volume = {340},
pages = {471--475},
doi = {10.1016/j.jad.2023.08.061}
}
EUVIMED